Fresenius Medical Care AG (BIT:1FME)
Italy
· Delayed Price · Currency is EUR 39.75
+0.71 (1.82%)
At close: Mar 5, 2026
Fresenius Medical Care AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 19,628 | 19,336 | 19,454 | 19,398 | 17,619 | Upgrade
|
| Revenue Growth (YoY) | 1.51% | -0.60% | 0.29% | 10.10% | -1.35% | Upgrade
|
| Cost of Revenue | 14,599 | 14,579 | 14,529 | 14,504 | 12,846 | Upgrade
|
| Gross Profit | 5,029 | 4,757 | 4,925 | 4,894 | 4,773 | Upgrade
|
| Selling, General & Admin | 3,033 | 3,143 | 3,196 | 3,170 | 2,773 | Upgrade
|
| Research & Development | 157.98 | 183.49 | 231.97 | 228.62 | 220.78 | Upgrade
|
| Other Operating Expenses | -31.65 | -109.03 | -26.86 | -43.25 | -124.41 | Upgrade
|
| Operating Expenses | 3,159 | 3,217 | 3,401 | 3,356 | 2,869 | Upgrade
|
| Operating Income | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 | Upgrade
|
| Interest Expense | -384.41 | -407.04 | -424.64 | -360.14 | -353.6 | Upgrade
|
| Interest & Investment Income | 69.61 | 71.58 | 88.22 | 67.66 | 73.17 | Upgrade
|
| Earnings From Equity Investments | 181.37 | 134.88 | 121.79 | 66.56 | 92.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -43.79 | -23.06 | -35.5 | -36.83 | -9.9 | Upgrade
|
| EBT Excluding Unusual Items | 1,693 | 1,316 | 1,273 | 1,275 | 1,706 | Upgrade
|
| Merger & Restructuring Charges | -104.37 | -317.48 | -259.92 | -147.95 | -37.55 | Upgrade
|
| Gain (Loss) on Sale of Investments | -77.04 | 44.03 | 14.67 | 44.85 | -87.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.99 | 14.66 | 4.84 | 47.17 | -8.63 | Upgrade
|
| Pretax Income | 1,512 | 1,057 | 1,033 | 1,219 | 1,572 | Upgrade
|
| Income Tax Expense | 320.97 | 316.06 | 300.56 | 324.95 | 352.83 | Upgrade
|
| Earnings From Continuing Operations | 1,191 | 740.87 | 732.46 | 894.33 | 1,219 | Upgrade
|
| Minority Interest in Earnings | -212.9 | -202.96 | -233.46 | -220.92 | -249.72 | Upgrade
|
| Net Income | 978.37 | 537.91 | 499 | 673.41 | 969.31 | Upgrade
|
| Net Income to Common | 978.37 | 537.91 | 499 | 673.41 | 969.31 | Upgrade
|
| Net Income Growth | 81.88% | 7.80% | -25.90% | -30.53% | -16.75% | Upgrade
|
| Shares Outstanding (Basic) | 291 | 293 | 293 | 293 | 293 | Upgrade
|
| Shares Outstanding (Diluted) | 291 | 293 | 293 | 293 | 293 | Upgrade
|
| Shares Change (YoY) | -0.76% | - | 0.06% | 0.06% | -0.41% | Upgrade
|
| EPS (Basic) | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 | Upgrade
|
| EPS (Diluted) | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 | Upgrade
|
| EPS Growth | 83.60% | 7.65% | -25.97% | -30.60% | -16.44% | Upgrade
|
| Free Cash Flow | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 | Upgrade
|
| Free Cash Flow Per Share | 6.06 | 5.75 | 6.63 | 4.92 | 5.58 | Upgrade
|
| Dividend Per Share | 1.490 | 1.440 | 1.190 | 1.120 | 1.350 | Upgrade
|
| Dividend Growth | 3.47% | 21.01% | 6.25% | -17.04% | 0.75% | Upgrade
|
| Gross Margin | 25.62% | 24.60% | 25.32% | 25.23% | 27.09% | Upgrade
|
| Operating Margin | 9.53% | 7.96% | 7.83% | 7.93% | 10.81% | Upgrade
|
| Profit Margin | 4.98% | 2.78% | 2.56% | 3.47% | 5.50% | Upgrade
|
| Free Cash Flow Margin | 9.00% | 8.72% | 9.99% | 7.44% | 9.28% | Upgrade
|
| EBITDA | 2,622 | 2,347 | 2,436 | 2,512 | 2,799 | Upgrade
|
| EBITDA Margin | 13.36% | 12.14% | 12.52% | 12.95% | 15.88% | Upgrade
|
| D&A For EBITDA | 752.56 | 807.31 | 912.07 | 973.66 | 894.89 | Upgrade
|
| EBIT | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 | Upgrade
|
| EBIT Margin | 9.53% | 7.96% | 7.83% | 7.93% | 10.81% | Upgrade
|
| Effective Tax Rate | 21.22% | 29.90% | 29.09% | 26.65% | 22.45% | Upgrade
|
| Revenue as Reported | 19,628 | 19,336 | 19,454 | 19,398 | 17,619 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.